# Tesamorelin in HIV: visceral fat loss over 52 weeks

Source: https://pepvault.app/research/tesamorelin-falutz-2010

Last updated: 2026-11-17

Use: © PepVault. Read and cite with a link. Copying, bulk scraping, rewriting or republishing is not permitted (https://pepvault.app/terms#content).

[Research](https://pepvault.app/research) [Tesamorelin](https://pepvault.app/research#tesamorelin)

Randomized trial · people

# Tesamorelin cut visceral fat 15.4% vs placebo in HIV at 26 weeks

Checked against the paper November 2026 Randomized trial [Published by PepVault](https://pepvault.app/guides/how-we-research)

## The takeaway

In people with HIV and extra belly fat on ART, tesamorelin shrank deep belly fat compared with placebo, and the loss held through 52 weeks in those who kept taking it.

- **Kind:** Randomized trial
- **Studied in:** People
- **Number studied:** 806
- **Published:** 2010
- **Journal:** J Clin Endocrinol Metab

## What they tested

The team tested whether tesamorelin shrinks visceral fat (deep fat around the organs) in people with HIV on antiretroviral therapy (ART, HIV medicines) who carry extra belly fat.

## How the study was done

A pooled analysis of two randomized, double-blind, placebo-controlled phase 3 trials in 806 people with HIV on ART, given a daily under-the-skin shot of tesamorelin 2 mg (543 people) or placebo, a dummy shot (263 people), for 26 weeks. A 26-week extension followed: some on tesamorelin were randomized again to stay on it (246) or switch to placebo (135), and those on placebo switched to tesamorelin (197).

<!--promo-->

PepVault for iPhone

## Taking tesamorelin? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-flow&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## What they found

At 26 weeks, visceral fat on CT scan fell by 24 cm² with tesamorelin and rose by 2 cm² with placebo, a treatment effect of -15.4%. Fat just under the skin of the belly did not change significantly, while triglycerides dropped by 37 mg/dl versus a 6 mg/dl rise on placebo, and IGF-I rose by 108 ng/ml versus a 7 ng/ml drop. Body image and patient and physician ratings of belly shape also improved. In people who stayed on tesamorelin for 52 weeks, visceral fat was down 35 cm² (17.5%) and waist size down 3.4 cm from the start, most people tolerated the drug, and glucose measures showed no meaningful differences between groups.

## What it doesn’t show

The placebo comparison lasted only 26 weeks; the 52-week results compare one group with its own starting point, not with placebo. Everyone studied had HIV and was on ART, so it does not show effects in other people.

## The paper

Falutz et al. Effects of tesamorelin (TH9507), a growth hormone-releasing factor analog, in human immunodeficiency virus-infected patients with excess abdominal fat: a pooled analysis of two multicenter, double-blind placebo-controlled phase 3 trials with safety extension data. J Clin Endocrinol Metab. 2010.

- [PubMed (PMID 20554713)](https://pubmed.ncbi.nlm.nih.gov/20554713/)
- [The paper (DOI 10.1210/jc.2010-0490)](https://doi.org/10.1210/jc.2010-0490)
- [ClinicalTrials.gov (NCT00123253)](https://clinicaltrials.gov/study/NCT00123253)

## The compound

- [Tesamorelin: how it works, half-life, studied range and evidence](https://pepvault.app/peptides/tesamorelin)
- [Tesamorelin dose guide](https://pepvault.app/lab/dosage/tesamorelin)

## With this study

### Tesamorelin

- [Tesamorelin: the full reference](https://pepvault.app/peptides/tesamorelin)
- [Tesamorelin dose guide](https://pepvault.app/lab/dosage/tesamorelin)

### Mixing charts

- [2 mg vial](https://pepvault.app/tools/reconstitution-calculator/tesamorelin-2mg)
- [10 mg vial](https://pepvault.app/tools/reconstitution-calculator/tesamorelin-10mg)

### Studies

- [Tesamorelin: visceral fat down 27.71 cm² in HIV lipodystrophy](https://pepvault.app/research/tesamorelin-badran-2026)
- [Tesamorelin shifted liver gene activity in HIV-related fatty liver](https://pepvault.app/research/tesamorelin-fourman-2020)
- [Tesamorelin: denser, larger trunk muscles at 26 weeks in HIV](https://pepvault.app/research/tesamorelin-adrian-2019)
- [All 12 studies](https://pepvault.app/research#tesamorelin)

### Compared with

- [Sermorelin vs Tesamorelin](https://pepvault.app/peptides/compare/sermorelin-vs-tesamorelin)
- [Ipamorelin vs Tesamorelin](https://pepvault.app/peptides/compare/ipamorelin-vs-tesamorelin)
- [HGH vs Tesamorelin](https://pepvault.app/peptides/compare/hgh-vs-tesamorelin)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### Terms on this page

- [Placebo](https://pepvault.app/glossary/placebo)

## More studies on Tesamorelin

- [Tesamorelin: visceral fat down 27.71 cm² in HIV lipodystrophy](https://pepvault.app/research/tesamorelin-badran-2026) Meta-analysis · people · 2026
- [Tesamorelin shifted liver gene activity in HIV-related fatty liver](https://pepvault.app/research/tesamorelin-fourman-2020) Randomized trial · people · 2020
- [Tesamorelin: denser, larger trunk muscles at 26 weeks in HIV](https://pepvault.app/research/tesamorelin-adrian-2019) Randomized trial · people · 2019
- [Tesamorelin: no change in glucose control in type 2 diabetes](https://pepvault.app/research/tesamorelin-clemmons-2017) Randomized trial · people · 2017
- [Tesamorelin cut visceral and liver fat over 6 months in HIV patients](https://pepvault.app/research/tesamorelin-stanley-2014) Randomized trial · people · 2014
- [Tesamorelin had little effect on simvastatin and ritonavir levels](https://pepvault.app/research/tesamorelin-teng-2013) Randomized trial · people · 2013
- [Every study on Tesamorelin](https://pepvault.app/research#tesamorelin)

Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed November 2026. Spot an error? [feedback@pepvault.app](mailto:feedback@pepvault.app). [How we research](https://pepvault.app/guides/how-we-research). This page reports one study; it is not medical advice.

<!--promo-->

[Track it in the app](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-next&mt=8)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Taking tesamorelin? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-end&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Taking tesamorelin? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-rail&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## With this study

### Tesamorelin

- [Tesamorelin: the full reference](https://pepvault.app/peptides/tesamorelin)
- [Tesamorelin dose guide](https://pepvault.app/lab/dosage/tesamorelin)

### Mixing charts

- [2 mg vial](https://pepvault.app/tools/reconstitution-calculator/tesamorelin-2mg)
- [10 mg vial](https://pepvault.app/tools/reconstitution-calculator/tesamorelin-10mg)

### Studies

- [Tesamorelin: visceral fat down 27.71 cm² in HIV lipodystrophy](https://pepvault.app/research/tesamorelin-badran-2026)
- [Tesamorelin shifted liver gene activity in HIV-related fatty liver](https://pepvault.app/research/tesamorelin-fourman-2020)
- [Tesamorelin: denser, larger trunk muscles at 26 weeks in HIV](https://pepvault.app/research/tesamorelin-adrian-2019)
- [All 12 studies](https://pepvault.app/research#tesamorelin)

### Compared with

- [Sermorelin vs Tesamorelin](https://pepvault.app/peptides/compare/sermorelin-vs-tesamorelin)
- [Ipamorelin vs Tesamorelin](https://pepvault.app/peptides/compare/ipamorelin-vs-tesamorelin)
- [HGH vs Tesamorelin](https://pepvault.app/peptides/compare/hgh-vs-tesamorelin)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### Terms on this page

- [Placebo](https://pepvault.app/glossary/placebo)

<!--promo-->

PepVault for iPhone

## Taking tesamorelin? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-sticky&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

## Research

- [All studies](https://pepvault.app/research)
- [Every study on Tesamorelin](https://pepvault.app/research#tesamorelin)

## The library

- [Tesamorelin](https://pepvault.app/peptides/tesamorelin)
- [Tesamorelin dose guide](https://pepvault.app/lab/dosage/tesamorelin)
- [The peptide reference library](https://pepvault.app/peptides)

## How we work

- [How we research](https://pepvault.app/guides/how-we-research)
- [How we check the library](https://pepvault.app/about#library)

PepVault is a research and tracking resource, not medical advice. Ranges are what studies used, never a dose for you. Brand names are trademarks of their owners; PepVault is independent of them.

PepVault is a private research and tracking tool, not medical advice. The information here is reference material from published literature and community use — always verify it and discuss any protocol with a qualified clinician before changing it.

© 2026 PepVault. Our text, data and tools may not be copied, scraped or republished without [permission](https://pepvault.app/terms#content).
